Homogeneous amplification nucleobase quenching assay to detect the E474Q LCHAD deficiency mutation.
Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency is a rare and potentially fatal autosomal recessive disorder of fatty acid metabolism. Early institution of dietary therapy is essential and places a premium on rapid diagnosis. Pregnancy with an LCHAD-deficient fetus is often complicated in the third trimester by liver disease, particularly acute fatty liver of pregnancy. All cases of isolated LCHAD deficiency have at least one copy of the E474Q mutation in the gene encoding the alpha-subunit of the mitochondrial trifunctional protein. Previously published methods for detecting this mutation are based upon allele-specific restriction enzyme digestion of a DNA fragment generated by PCR, followed by gel electrophoresis to resolve the products. We have developed a faster and less expensive assay for the E474Q mutation using PCR followed directly by differential melting of a fluorescently labeled oligodeoxyribonucleotide probe, using nucleobase quenching to detect probe hybridization.
McClaskey
John H
JH
Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.
Leman
Adam R
AR
Rothberg
Paul G
PG
D015094:3-Hydroxyacyl CoA Dehydrogenases / Q000235:genetics*; D005227:Fatty Acids / Q000378:metabolism*; D005453:Fluorescence; D006801:Humans; D008052:Lipid Metabolism, Inborn Errors / Q000175:diagnosis* / Q000235:genetics; D063989:Long-Chain-3-Hydroxyacyl-CoA Dehydrogenase; D009154:Mutation; D016133:Polymerase Chain Reaction / Q000379:methods*
D005227:Fatty Acids; D015094:3-Hydroxyacyl CoA Dehydrogenases; D063989:Long-Chain-3-Hydroxyacyl-CoA Dehydrogenase